PUBLISHER: The Business Research Company | PRODUCT CODE: 1889301
PUBLISHER: The Business Research Company | PRODUCT CODE: 1889301
Antimicrobial resistance (AMR) genotyping panels are advanced molecular diagnostic tools used to detect, identify, and analyze genes linked to antimicrobial resistance in bacteria and other pathogens. They allow the simultaneous screening of multiple resistance markers, enabling faster and more accurate identification of resistant strains.
The primary components of AMR genotyping panels include custom panels and pre-designed panels. AMR genotyping custom panels are specialized molecular testing panels created to detect specific genetic markers responsible for antimicrobial resistance in bacteria, viruses, or other pathogens. The technologies used include polymerase chain reaction (PCR)-based methods, microarray-based methods, next-generation sequencing (NGS)-based methods, and others, which support applications in clinical diagnostics, research, drug development, and other specialized fields. These panels are utilized by hospitals and clinics, research institutes, pharmaceutical and biotechnology companies, and other healthcare and scientific organizations.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The antimicrobial resistance (AMR) genotyping panels market research report is one of a series of new reports from The Business Research Company that provides antimicrobial resistance (AMR) genotyping panels market statistics, including antimicrobial resistance (AMR) genotyping panels industry global market size, regional shares, competitors with an antimicrobial resistance (AMR) genotyping panels market share, detailed antimicrobial resistance (AMR) genotyping panels market segments, market trends and opportunities, and any further data you may need to thrive in the antimicrobial resistance (AMR) genotyping panels industry. This antimicrobial resistance (AMR) genotyping panels market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The antimicrobial resistance (AMR) genotyping panels market size has grown rapidly in recent years. It will grow from $1.26 billion in 2024 to $1.45 billion in 2025 at a compound annual growth rate (CAGR) of 14.6%. Growth during the historic period can be attributed to the expansion of diagnostic infrastructure, the rising burden of infectious diseases, increasing misuse and overuse of antibiotics, higher healthcare expenditure, and greater awareness of antimicrobial resistance (AMR).
The antimicrobial resistance (AMR) genotyping panels market size is expected to see rapid growth in the next few years. It will grow to $2.46 billion in 2029 at a compound annual growth rate (CAGR) of 14.2%. Growth in the forecast period can be linked to the rising demand for genotyping panels, collaborative efforts among public health agencies, the presence of established healthcare systems, growing awareness of AMR, and continued expansion of diagnostic infrastructure. Key trends expected during the forecast period include advancements in genotyping technologies, the integration of advanced molecular diagnostics, the adoption of next-generation sequencing (NGS), the use of high-throughput PCR-based platforms, and technological progress in cloud-based analytics.
The rising prevalence of antimicrobial-resistant infections is expected to drive the growth of the antimicrobial resistance (AMR) genotyping panels market in the coming years. Antimicrobial-resistant infections are caused by microorganisms-including bacteria, viruses, fungi, or parasites-that have evolved mechanisms to withstand standard antimicrobial treatments, making infections more difficult to treat. The overuse and misuse of antibiotics have accelerated the development of resistant pathogens, increasing the need for AMR genotyping panels that can rapidly detect resistance genes and guide targeted antimicrobial therapy. For example, according to the Centers for Disease Control and Prevention (CDC), over 2.8 million antimicrobial-resistant infections occur annually in the United States. Therefore, the rising prevalence of antimicrobial-resistant infections is contributing to the growth of the AMR genotyping panels market.
Key players in the antimicrobial resistance (AMR) genotyping panels market are focusing on innovative product development, such as multiplex PCR-based research assays, to enable simultaneous detection of multiple pathogens and antibiotic resistance genes in a single test, thereby improving research efficiency and accelerating the identification of emerging resistance patterns. Multiplex PCR-based research assays are molecular tests that amplify and detect multiple genetic targets in a single reaction to identify pathogens and resistance genes simultaneously. For instance, in September 2025, Molecular Designs, a U.S.-based molecular diagnostics and research-assay company, launched the Urogenital Microbiota with ABX 53 Simplicity Panel. This multiplex PCR-based research assay detects urinary pathogens and antibiotic resistance genes in a single test, covering 28 urogenital and urinary microbial targets (20 bacterial, 7 fungal, and 1 protozoan) along with 25 antibiotic-resistance gene markers. It offers same-day turnaround and is available in both 96-well and 384-well plate formats, with breakaway panels included in the 96-well version to reduce waste.
In June 2025, bioMerieux, a France-based provider of in vitro diagnostics systems, reagents, software, and services for infectious diseases and industrial microbiology, acquired the assets of Day Zero Diagnostics for $25 million. Through this acquisition, bioMerieux aimed to strengthen its next-generation sequencing (NGS) and rapid antimicrobial-resistance diagnostics capabilities to better address infectious disease and antimicrobial resistance (AMR) challenges. Day Zero Diagnostics is a U.S.-based company specializing in rapid whole-blood sample preparation, genome sequencing, and machine-learning analytics for pathogen identification and antibiotic-resistance profiling.
Major companies operating in the antimicrobial resistance (amr) genotyping panels market are Thermo Fisher Scientific Inc., F Hoffmann La Roche Ltd., Abbott Laboratories, Illumina Inc., bioMerieux SA., Bruker Corporation, QIAGEN NV., Cepheid Inc., Integrated DNA Technologies Inc., Seegene Inc., Oxford Nanopore Technologies plc., Streck Inc., MedGenome Inc., Vela Diagnostics Pte. Ltd., Agena Bioscience Inc., CD Genomics Inc., Curetis GmbH, T2 Biosystems Inc., 3B BlackBio Biotech India Ltd., Genefirst Ltd., OpGen Inc.
North America was the largest region in the antimicrobial resistance (AMR) genotyping panels market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in antimicrobial resistance (AMR) genotyping panels report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the antimicrobial resistance (AMR) genotyping panels market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The antimicrobial resistance (AMR) genotyping panels market consists of sales of qPCR antimicrobial resistance detection kits, multiplex genotyping assays, next-generation sequencing reagent kits, antimicrobial resistance reference standards, and microarray slide kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Antimicrobial Resistance (AMR) Genotyping Panels Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on antimicrobial resistance (amr) genotyping panels market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for antimicrobial resistance (amr) genotyping panels ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The antimicrobial resistance (amr) genotyping panels market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.